For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS

Coronavirus

Coronavirus News is a section dedicated to the new coronavirus that is causing an epidemic in China and fast spreading globally. The strain of coronavirus called Covid-19 or also commonly called the Wuhan coronavirus is genetically more potent and faster spreading than the SARS coronavirus. Currently teams are working to develop a new vaccine for this new coronavirus while other teams are trying t...
Source: Long COVID Research  Oct 04, 2021  3 years ago
Long COVID Research: A new study by researchers from McMaster University-Canada and University of Melbourne- Australia has found that individuals that only had mild COVID-19 infections still exhibited persistent leukocyte changes even three months after ‘recovery’!   It has been found that survivors of severe SARS-CoV-2 infections frequently suffer from a range of post-infection ...
Source: Vitamin D-COVID-19   Oct 03, 2021  3 years ago
UK Scientists Provides More Proof That Vitamin D Protects Against Severe COVID-19 Disease And Death While Questionable Canadian ‘Researchers’ Say Otherwise!   Vitamin D and COVID-19: A new study by researchers from Trinity College Dublin and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiati...
Source: SARS-CoV-2-LRRC15   Oct 03, 2021  3 years ago
SARS-CoV-2 and LRRC15: A new study by researchers from Wellcome Sanger Institute-UK, University of Cambridge-UK, Leibniz Institute for Primate Research-Germany, Georg-August University Göttingen-Germany and University of York has revealed that the protein called LRRC15 (Leucine-rich repeat containing 15) gene previously unknown to be involved in SARS-CoV-2 infection, is seen to interact with ...
Source: Blood Thinners-COVID-19  Oct 02, 2021  3 years ago
Blood Thinners-COVID-19: A new study by researchers from University of Minnesota-USA and Basel University-Switzerland has found that outpatients with COVID-19 who were on outpatient blood thinners at the time of diagnosis experienced a 43% reduced risk of hospitalization. The study focused on COVID-19 positive patients who have been taking prescribed anticoagulant class rugs including warfarin, a...
Source: Hyperglycemia and COVID-19  Oct 02, 2021  3 years ago
Hyperglycemia and COVID-19: A new study by researchers from Weill Cornell Medicine-New York, USA has shown that COVID-19 not only is able to trigger hyperglycemia but it also disrupts fat cells and causes decreased production of the hormone Adiponectin especially in stages of disease severity.   Adiponectin (also referred to as GBP-28, apM1, AdipoQ and Acrp30) is a protein hormone and a...
Source: SARS-CoV-2 Research  Oct 01, 2021  3 years ago
SARS-CoV-2 Research: A new study by researchers from University of Rochester has uncovered that the receptors ACE2 has novel protein interactions that are disrupted during SARS-CoV-2 infection, contributing to the spectrum of COVID-19 pathologies! The ACE2 or angiotensin-converting enzyme 2 is the cell receptor that the SARS-CoV-2 coronavirus binds to and uses to enter and infect human cells. &n...
Source: Asymptomatic COVID-19  Oct 01, 2021  3 years ago
To date, almost 235 million people globally have been infected with the SARS-CoV-2 coronavirus according to official figures but in reality, as even proposed by the WHO and US CDC, these figures are much higher and could be even as high as five to eight fold!   However a majority of individuals upon infection with the SARS-CoV-2 virus are either asymptomatic or only suffer mild conditions of...
Source: SARS-CoV-2 ADE   Sep 30, 2021  3 years ago
ADE and SARS-CoV-2 Variants: A new study by researchers from University of Wisconsin-Madison has shockingly revealed that Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is mediated by the IgG Receptors FcγRIIA and FcγRIIIA but does not contribute to aberrant cytokine production by macrophages.   The study also warns that the new emerging SARS-CoV-2 variants could actually...
Source: COVID-19 Research  Sep 30, 2021  3 years ago
COVID-19 Research: A new study by researchers from Yale University, Harvard University and Rockefeller University has found that the SARS-CoV-2 coronavirus is not only able to penetrate into the human host macrophages but also replicates in them while triggering an inflammatory cascade and interferon upregulation that often results in COVID-19 disease severity.   A macrophage is an important...
Source: Intramuscular Injections  Sep 29, 2021  3 years ago
The COVID-19 vaccines are meant to be injected intramuscularly and there is a safe technique in which when the needle is inserted, the syringe should be pulled back a bit to see if there is blood and if there is blood, then that means that a vessel has been penetrated and the needle should be withdrawn and re-injected again to another site, always making sure that that no vessels are penetrated an...
Source: Singapore COVID-19 News  Sep 29, 2021  3 years ago
Singapore COVID-19 News: First it was Israel and then Singapore, both model countries for take up rates of COVID-19 vaccines that are now seeing new surges of COVID-19 infections among both the vaccinated and unvaccinated. And mind you not all cases are mild among the vaccinated as what most mainstream Western media are propagating it to be. Cases of disease severity, hospitalizations and deaths a...
Source: B.1.1.523-Variant  Sep 28, 2021  3 years ago
B.1.1.523 variant: Researchers from Maastricht University Medical Center-Netherlands and the South Limburg Public Health 9 Service-Netherlands has identified yet another new SARS-CoV-2 variant B.1.1.523 that most probably originated from Russia and that combines many spike mutations linked to immune evasion from current variants of concern (VOC). The worrisome variant is fast spreading in Germany ...
Source: SARS-CoV-2-Brain  Sep 28, 2021  3 years ago
SARS-CoV-2-Brain:  A new preliminary but large-scale study led researchers from the Department of Clinical Neurosciences of the University of Oxford-UK, along with scientist from  National Institutes of Mental Health, National Institutes of Health-USA and the Department of Brain Sciences, Imperial College-UK  investigating brain changes in individuals who had experienced COVID-19 dr...
Source:  Sep 27, 2021  3 years ago
COVID-19 and the Heart:The European Society of Cardiology and its researchers are warning that the SARS-CoV-2 coronavirus that causes the COVID-19 disease also affects the heart in so many ways and that fatalities and excess deaths due to COVID-19 induced heart issues are also rising.   The report was published in the peer reviewed e-Journal of Cardiology Practice (An official journal of the...
Source: COVID-19 Herbs  Sep 27, 2021  3 years ago
COVID-19 Herbs: A new study by American researchers from Eastern Virginia Medical School-Virginia, Rush University Medical Center-Illinois and  Loyola University Chicago- Illinois has found that the phytochemical ginkgolic acid that is obtained from gingko biloba shows promising prospects as an antiviral to treat COVID-19 after finding that it was able to inhibit the infection of the coronavi...
Source: COVID-19-Autoimmune Diseases   Sep 26, 2021  3 years ago
COVID-19 And Autoimmune Diseases: Various new studies are showing that an infection with the SARS-CoV-2 can also trigger a variety of autoimmune conditions and diseases including some never seen before.   In the first study by researchers from Stanford University School of Medicine-USA, the study team found that in severe hospitalized COVID-19 patients, the immune system is tricked into prod...
Source: COVID-19 Research  Sep 26, 2021  3 years ago
COVID-19 Research: Day by day newer study findings and data are emerging that gives us a more detailed perspective about the COVID-19 disease caused by the SARS-CoV-2 coronavirus. Some of these findings add to the list of things that we already know while some supersede previous assumptions or weak study findings about the pathogenesis of the SARS-CoV-2 virus and the human host cellular pathway re...
Source: Emerging Delta Sub-Variants-AY.29  Sep 25, 2021  3 years ago
Thailand Medical News is warning that a new Delta sub-variant called AY.29 with two more distinct mutations on it ie C5239T And T5514C that most probably became predominant in Japan in June 2021 could be more transmissible.   We are also warning that new mutations have been found on this new lineage ie C28170T (ORF8: P93S) and C5365T mutations since August 2021 and these new evolved forms of...
Source: COVID-19 Research  Sep 25, 2021  3 years ago
COVID-19 Research: A new study led by researchers from University of Kent-UK and Goethe University-Germany has discovered that a protein that is a component of the human immune system called CD47, found on cell surfaces plays a contributing factor to COVID-19 disease severity.   Typically most SARS-CoV-2 infections are mild or even asymptomatic. However, a small fraction of infected individu...
Source: COVID-19 Exposé   Sep 24, 2021  3 years ago
COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few.   http...
Source: COVID-19 News  Sep 24, 2021  3 years ago
COVID-19 News: A new study by researchers from the Genos Glycoscience Research Laboratory-Croatia and the University of Zagreb-Croatia has shockingly found that the SARS-CoV-2 coronavirus is able to not just bind to the ACE2 receptors but also are able to bind to 13 other identified human host receptors.   These host receptors include:   1. C-type lectin receptors 2. Mannose-binding lec...
Source: Guillain-Barré Syndrome and COVID-19  Sep 23, 2021  3 years ago
Guillain-Barré Syndrome and COVID-19: A new international collaborative study has confirmed that SARS-CoV-2 infections can trigger Guillain-Barré Syndrome.   Guillain-Barré syndrome (GBS) is a rare, autoimmune disorder in which a person's own immune system damages the nerves, causing muscle weakness and sometimes paralysis. GBS can cause symptoms that ...
Source: SARS-CoV-2 R.1 Variant   Sep 23, 2021  3 years ago
R.1 Variant: A new SARS-CoV-2 variant called R.1 has reemerged after months of gaining viral fitness and relevant mutations on its genome to make it truly virulent, potent, extremely transmissible and immune evasive. The R.1 may be easier to contract due to protein mutations within the spike protein of the virus and its ability to be easily transmitted from person to person despite vaccination sta...
Source: COVID-19-Drugs  Sep 22, 2021  3 years ago
COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms.   Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...
Source: America Medical News  Sep 22, 2021  3 years ago
U.S. Medical News: American media are reporting that for the first time since early March 2021, COVID-19 death rates are once again climbing in the country with daily rates now topping almost 1,900.   As of today, (22nd September, 2021) according to statistics from Worldometer site, more than 43.2 million Americans have been infected with the SARS-CoV-2 coronavirus and more than 696,867 Amer...
Source: COVID-19 Immunology  Sep 22, 2021  3 years ago
COVID-19 Immunology: A new study by researchers from Cedars-Sinai Medical Center-California not only confirms that SARS-CoV-2 infections whether symptomatic (Be it Mild, Moderate or Severe) or even asymptomatic can generate distinct autoantibodies that can lead to a variety of autoimmune issues not only during the infection stage but also in the long term. The study has also found that males tend ...
Source: COVID-19 Research  Sep 21, 2021  3 years ago
COVID-19 Research: A new study led by German researchers from the Center for Infection and Genomics of the Lung (CIGL), Universities of Giessen and Marburg Lung Center, Giessen-Germany along with scientist from numerous other German research institutions have shockingly found that the SARS-CoV-2 induces the formation of unique and different and fibrin clot structures never seen before in the human...
Source: Medical News  Sep 21, 2021  3 years ago
Medical News: For a long time now, a lot of research on the SARS-CoV-2 coronavirus mode of infection and pathogenesis has only been focuses on the spike proteins with very little paid to the rest of the proteins found on the viral genome.   A new study by German scientists from Berlin Institute for Medical Systems Biology and the Max Delbrück Center for Molecular Medicine-Berlin and the...
Source: B.1.1.519  Sep 21, 2021  3 years ago
B.1.1.519 Variant Researchers are warning that the Mexican variant B.1.1.519 which has been ravaging Mexico for a few months now not only causes an increased risk of hospitalization and disease severity but also increased the risk of mortality. Further just like the Delta and Mu variants, it is spawning sub-variants that are of concern.   Two studies have already been published by Mexican re...
Source: COVID-19 Immunology  Sep 20, 2021  3 years ago
COVID-19 Immunology: A new study by led by researchers from University of Amsterdam-Netherlands along with support by scientists from Weill Medical College of Cornell University-USA has found that SARS-CoV-2 infections typically activate the human dendritic cells via cytosolic receptors rather than by extracellular Toll-like receptors (TLRs).   Typically, the human immune system needs to rec...
Source: COVID-19 Mortality  Sep 20, 2021  3 years ago
COVID-19 Mortality: A new research led by scientist from Oxford University-UK that also involved researchers from St. George’s University of London-UK, St. George’s Hospital NHS Trust-UK and the  Massachusetts Institute of Technology-USA has found that most fatal COVID-19 cases are due to weak immune responses and elevated MAIT(elevated mucosal associated invariant) cell acti...
Source: Long COVID News  Sep 19, 2021  3 years ago
Long COVID News: A new study led by researchers from Columbia University-USA along with support of scientists from the Zan Mitrev Clinic-North Macedonia and University of Florence-Italy has found that Long-COVID is associated with sustained biochemical disturbances especially elevated levels of D-dimers and Ferritin.   The Study team aimed to evaluate the incidence of Post-Acute Sequelae of ...
Source: SARS-CoV-2 Variants  Sep 19, 2021  3 years ago
SARS-CoV-2 Variants: A new study by Taiwanese researchers from the Academia Sinica and National Taiwan University along with support by scientists from  the Medical University of Lublin-Poland and Johns Hopkins University-USA has found that the different SARS-CoV-2 variants not only have different mutations and deletions on them but most importantly they exhibit different but unique spike str...
Source: Sunday COVID-19 Briefs  Sep 19, 2021  3 years ago
Sunday COVID-19 Briefs   WHO While Encouraging Vaccination, Refuses To Reveal Vaccination Data Of Its Own Staff   WHO, a United Nations' health agency, which has repeatedly urged the world to get vaccinated against COVID-19 and other illnesses, on Friday declined to say how many of its own staffers have followed that advice.   Dr Margaret Harris, a World Health Organization spo...
Source: COVID-19 Supplements-Flavonoids  Sep 18, 2021  3 years ago
COVID-19-Supplements: As part of Thailand Medical News continued initiatives on herbs and phytochemical research for treating COVID-19 and also Long COVID, the following coverage on the usage of herbs and phytochemicals to treat COVID-19 and a health conditions arising with the novel coronavirus infection or what is termed as Long COVID or PASC (Post-acute Sequelae of COVID-19) shows the growing i...
Source: SARS-CoV-2 Variants  Sep 18, 2021  3 years ago
SARS-CoV-2 Variants: French researchers in a new study have identified a new Delta sub-variant that is of concern as it not only possess the unique mutation S:E484Q found on the Kappa variant but it also has the S:T95I mutation found on the Iota variant that is associated with breakthrough infections!   Alarmingly other mutations were also found on the new Delta sub-variant phylogenetic clus...
Source:Hypertension And mRNA Vaccines  Sep 18, 2021  3 years ago
A study by researchers from Lausanne University Hospital-Switzerland has found that an extremely small percentage of otherwise healthy individuals who receive the mRNA vaccines such as those by Pfizer or Moderna, run the risk of developing stage III hypertension upon vaccination. The study findings were published in the peer reviewed journal: Hypertension (A Journal of the American Heart Associat...
Source: Women’s Health  Sep 17, 2021  3 years ago
UPDATED 17th October 2021:After the publication of our article on September 17th, numerous researchers responded and a team from Washington University in St. Louis, University of Illinois and Harvard University got together to conduct a detailed study which confirms that the COVID-19 vaccines does cause increased menstrual bleeding and also disrupts and causes irregular menstruation periods.  ...
Source: SARS-CoV-2 Airborne  Sep 17, 2021  3 years ago
SARS-CoV-2 Airborne: As predicted by Thailand Medical News in our earlier coverage, study findings by researchers from the University of Maryland shows that the SARS-CoV-2 coronavirus is evolving to become even better at airborne transmissions.   To date, SARS-CoV-2 epidemiology implicates airborne transmission but aerosol infectiousness and impacts of masks and variants on aerosol shedding ...
Source: COVID-19 Research  Sep 17, 2021  3 years ago
COVID-19 Research: A new private study by researchers from Vanda Pharmaceuticals Inc, a global biopharmaceutical company focused on the development and commercialization of innovative therapies located in Washington DC-USA  has uncovered that the chemokine receptor and the chemokine CXCR6/CXCL16 plays a key role in the in  the immuno-pathogenesis of severe COVID-19.  ...
Source: Long COVID News  Sep 17, 2021  3 years ago
Long COVID News: A new study by researchers from the University of Texas-Arlington shows that young and otherwise healthy adults would suffer persistent peripheral macrovascular and microvascular complications following ‘recovery’ from COVID-19.   The study was the first to investigate the persistent effects of COVID-19 on vascular function in otherwise healthy young adults. &nbs...
Source: COVID-19-Myocarditis  Sep 16, 2021  3 years ago
COVID-19 and Myocarditis: A new study by researchers from the Drug Safety Research Unit, Southampton-UK and the School of Pharmacy and Biomedical Sciences, University of Portsmouth-UK warns about the occurrences of myocarditis and pericarditis in men following mRNA-based COVID-19 vaccination. Though considered rare events, the number of cases being reported worldwide is of a concern.   The s...
Source: COVID-19 Drugs  Sep 16, 2021  3 years ago
COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...
Source: COVID-19 Supplements-Quercetin  Sep 15, 2021  3 years ago
COVID-19 Supplements: Since Thailand Medical News first covered a collection of studies in August 2020 showing that Quercetin could be used as adjuvant to treat COVID-19, its effectiveness has since been proven in many subsequent studies and even randomized clinical trials. https://www.thailandmedical.news/news/breaking-supplements-for-covid-19-quercetin-emerging-as-an-adjuvant-for-covid-19-treatm...
Source: New SARS-CoV-2 Variants  Sep 15, 2021  3 years ago
New SARS-CoV-2 Variants: Researchers from the City University of New York, University of Missouri-School of Medicine and The New School-New York (A private university) have in a new study alarmingly come across four new unique “cryptic” lineages of the SARS-CoV-2 coronavirus ie WNY1, 2, 3, and 4, from  wastewater sites. Shockingly these new variants had an assortment of mutations ...
Source: COVID-19-Innovations  Sep 14, 2021  3 years ago
COVID-19 Innovations: Scientist from Ohio State University along with researchers from the Ford Research and Innovation Center-Michigan have in a new study explored the use of heat treatments to inactivate SARS-CoV-2 in passenger vehicles including cars, van and buses.   According to the study abstract, “Heat is an established method to inactivate coronaviruses, and there is utility in...
Source: Thailand Coronavirus News  Sep 14, 2021  3 years ago
Thailand Coronavirus News: A very strange and confusing thing happened yesterday, local Thai health officials released data to the media saying that of those who died from COVID-19, 14.4% had already received the first dose of the COVID-19 vaccine.   Perhaps they were trying to point to the fact that a single dose of COVID-19 vaccine does not guarantee survival if infected. However various c...
Source: Medical Alerts  Sep 14, 2021  3 years ago
Medical Alert: Yet another alarming study finding on the multitude of negative effects that the novel coronavirus has on the human host, this time from a research by scientist from Yale University School of Medicine, Icahn School of Medicine at Mount Sinai, and Iowa State University. The research findings reveals that the SARS-CoV-2 coronavirus expresses a microRNA or miRNA called vmiR-5p that is ...
Source:Long-COVID News  Sep 14, 2021  3 years ago
Long-COVID News: Scientists from the University of Vermont-USA along with support from researchers from Duke University School of Medicine-North Carolina-USA have in a new study confirmed that the SARS-CoV-2 coronavirus has the ability able to cause damage to the DNA and telomeres of the human host. The study findings has alarming implications in terms of long term medical conditions and also help...
Source: COVID-19 News  Sep 13, 2021  3 years ago
COVID-19 News: A new study led by Brazilian researchers from the University of São Paulo that also included scientists from the University of Campinas, Universidade do Estado do Amazonas, Universidade Federal do Amazonas, Hospital Israelita Albert Einstein and other institutions have found that acid pH enhances SARS-CoV-2 infection by up-regulating the ACE2 receptors and found that individu...
Source: A Letter To Thailand Medical News  Sep 12, 2021  3 years ago
A Letter To Thailand Medical News: The world is getting crazy day by day all because of those controlling the COVID-19 narratives. I am all for vaccines but vaccines that fully work and are 100% safe. Not vaccines that cannot stop the spread of a disease. Not vaccines that allow breakthrough infections. And certainly note that vaccines that cannot stop disease severity, hospitalizations and mortal...
Source: SARS-CoV-2 Research  Sep 12, 2021  3 years ago
SARS-CoV-2 Research: Chinese scientist from Shandong University in Jinan-China have discovered that the SARS-CoV-2 ORF9b  proteins  are able to inhibit type I and III interferon (IFN) response and production by targeting various components of various immune signaling pathways.   The study findings were published in the peer reviewed Journal of Medical Virology. https://onlinelibrar...
Source: Latest COVID-19 Research  Sep 12, 2021  3 years ago
Latest COVID-19 Research: Chinese researchers from Nanjing University, Wuhan Institute of Virology, National Center of Gerontology at Beijing Hospital and the Army Engineering University of PLA have in a new breakthrough study identified 4 human host exosomal miRNAs that possess antiviral properties and are able to inhibit the SARS-CoV-2 coronavirus. Furthermore it was found that varying amounts o...
Source: COVID-19 Research  Sep 11, 2021  3 years ago
COVID-19 Research: A new breakthrough study by scientist from New York University Grossman School of Medicine has found SARS-CoV-2 induced hyperactive platelets’ unique genes S1000A8 and  S1000A9 causes the platelets to produce more myeloid-related proteins (MRP) 8 and 14 that contribute to increased inflammation, clotting, disease severity and longer hospital stays. The study also show...
Source: India Medical News  Sep 11, 2021  3 years ago
India Medical News: India’s Prime Minister Narendra Modi on Friday (10th September 2021) chaired a high-level meeting on the COVID situation, preparations and vaccination status as the government noted high caseloads in states like Kerala and Maharashtra. A government spokesman on conditions of anonymity said that the meeting was called for urgently as there has been ‘domestic and...

MOST READ

Nov 26, 2024  29 days ago
Nikhil Prasad
Nov 19, 2024  1 month ago
Nikhil Prasad
Nov 05, 2024  2 months ago
Nikhil Prasad
Nov 05, 2024  2 months ago
Nikhil Prasad
Jul 25, 2024  5 months ago
Nikhil Prasad
Jul 24, 2024  5 months ago
Nikhil Prasad
Jun 10, 2023  2 years ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer

Interesting Reads

Nikhil Prasad
Oct 21, 2024  2 months ago
Nikhil Prasad
Oct 02, 2024  3 months ago
Nikhil Prasad
Jul 23, 2024  5 months ago
Nikhil Prasad
Jun 22, 2024  6 months ago
COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023  2 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  5 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  5 years ago
Source: Myocardial Injury
Jun 09, 2020  5 years ago